12/9/2016NDRC, MOFCOM Release Draft Revision of Foreign Investment Industrial G...

12/8/2016Recent Executive Moves

12/8/2016Chi-Med Presents Pre-Clinical Data for Selective Syk Inhibitor HMPL-52...

12/8/2016WSJ: China's Medtronic Fine May Signal Health-Care-Cost Crackdown

12/8/2016Mandarin Capital Acquires Stakes In Italian Drug Firm Mipharm

12/8/2016NHFPC Issues Notice over Implementation of 1,001 Clinical Pathways

12/7/2016NDRC Fines MedTronic CNY 118.5M for Alleged Price-fixing

12/6/2016Pharma MNC's China Performance Rose Only 4% on Average in Q3/2016

12/6/2016BMS Terminates OTC Business Division in China

12/6/2016CFDI Solicits Comments on New Technical Guideline Documents

12/6/2016CDE Seeks Public Comments on Draft Drug Evaluation Document

12/6/2016Zhejiang Huahai’s Unit Buys Charlotte Facility from Par Pharma Subsdi...

12/5/2016CASI Pharma Files Import Drug Application For EVOMELA in China

12/5/2016China's Health Care Reforms Set to Benefit Top Domestic Pharmas

12/5/2016Chinese Ex-Hospital Prescription Drug Sales Forecasted to Exceed CNY 4...

12/5/2016Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...

12/5/2016Sanofi, JHL Biotech Forms Strategic Partnership for Biologics in China

12/1/2016Biopharmaceutical Manufacturing Growing Rapidly in China

12/1/2016Chinese CRO dMed Raises $8M in Series A Funding Round

12/1/2016AstraZeneca Gets Shot in the Arm with China Market

12/1/2016How Pharma Companies Can Keep Winning in China’s Changing Market

12/1/2016Recent Executive Moves

12/1/2016MIIT: Chinese Pharma Industry on Healthy Growth in the First 3Qs of 20...

12/1/2016The First Third Party Drug Exchange Established in Wuhan

11/30/2016Financial-related Company News in Brief

11/30/2016Balancing Act: China's Online Healthcare System Needs Both Innovation ...

11/30/2016MicuRx Initiates Phase 1 Clinical Trial in U.S. for Novel Antibiotic A...

11/30/2016Beijing Uniforms BMI Drug Reimbursement of Hospitals and Community Hea...

11/29/2016CBMG to Commence Phase I Trial in China for Non-Hodgkin Lymphoma Drug

11/29/2016AstraZeneca Adopts “Lean In” Strategy in China as Business Grows 15%...

Page:197/360 Total number of articles:10791: [First][<<] [195] [196] [197] [198] [199] [>>] [End]